News

MONTCO Today on MSN9h
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...
Pharmabiz11h
Merck Animal Health’s Bravecto Quantum receives US FDA approval to treat and protect dogs from fleas and ticks
Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...
FDA approves shot that protects dogs from fleas and ticks for 8-12 months
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
Top Analyst Reports for Microsoft, Alibaba & Merck
MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
Blockbuster long acting flea and tick treatment for dogs coming after FDA approval
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).